Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data LanzaTech Global, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2022
FY2023
FY2024
FY2025
Revenue
37.3
62.6
49.6
55.8
Research and development
53.2
68.1
77
53.2
Selling, general and administrative
26.8
50.4
50
47
General and administrative
5.92
Operating income
-75.6
-106
-109
-79.2
Other non-operating income
-2.75
-24.8
-14.6
42.8
Pre-tax income
-1.05
-131
-123
-44.7
Income tax
0
0
0
0
Net income
-76.4
-134
-138
-49
EBITDA
-70.9
-101
-103
-74.9
EPS, basic
-1,232.00
-78.67
-69.71
-22.27
EPS, diluted
-1,232.00
-78.67
-69.71
-22.27
Shares, basic (weighted)
0.09
1.77
1.98
2.2
Shares, diluted (weighted)
0.09
1.77
1.98
2.2
Balance sheet
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
83
75.6
43.5
13.2
Short-term investments
0
Inventory
1.13
1.75
2.16
0.68
Other current assets
11.2
12.6
15
10.5
Total current assets
124
173
99.3
39.7
Property, plant and equipment
19.7
22.8
22.3
17.1
Lease right-of-use assets
6.97
18.3
26.8
14.4
Other non-current assets
0.75
5.74
6.87
0.75
Total assets
177
242
175
100
Accounts payable
7.46
4.06
5.29
10.9
Accrued liabilities
2.26
5.47
2.3
1.84
Deferred revenue
3.1
3.2
6.17
0.42
Total current liabilities
56
27.8
30.4
27.7
Long-term debt
50
25.2
Lease liabilities
6.62
19.8
30.6
16.4
Other non-current liabilities
1.59
1.42
0.59
0.01
Total liabilities
125
127
161
90.9
Total debt
50
25.2
Paid-in capital
24.8
944
982
1,013
Retained earnings
-456
-832
-970
-1,019
Other comprehensive income
2.74
2.36
1.39
1.44
Shareholders' equity
-429
114
13.4
-3.89
Total equity
-429
114
13.4
-3.89
Total liabilities and equity
177
242
175
100
Shares outstanding
0.1
1.97
1.95
2.32
Cash flow statement
FY2022
FY2023
FY2024
FY2025
Net income
-1.36
-134
-138
-49
Depreciation and amortization
4.66
5.45
5.57
4.23
Stock-based compensation
2.53
15.2
13.2
7.2
Deferred income tax
0
0
0
0
Change in receivables
-8.82
0.1
0.56
-0.12
Change in payables
2.41
-4.99
-1.79
5.12
Cash from operations
-84.7
-97.3
-89.1
-64.9
Capital expenditures
-10.7
-8.55
-5.31
-1.26
Purchases of investments
0
-93.9
-27.1
0
Cash from investing
-10.7
-57.9
28.4
11.2
Debt repaid
0
-12.5
Stock issued
0
2.55
0.3
0
Share buybacks
-0.65
-7.65
-0.05
0
Cash from financing
50.5
148
30.2
25.6
Exchange rate effect
-0.18
-0.4
-0.05
-0.6
Net change in cash
-0.34
-7.43
-30.5
-28.7
Free cash flow
-95.4
-106
-94.4
-66.1
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $6.03 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-61.0%
Operating income / revenue.
EBITDA margin
-53.6%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
295.7%
Net income / revenue.
FCF margin
-58.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-56.1%
Cash from operations / revenue.
Return on equity (ROE)
66.1%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
53.4%
Net income / average total assets.
Return on invested capital (ROIC)
-13.0%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
47.5%
Research and development expense / revenue.
SG&A / revenue
50.7%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
8.1%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
1.9%
Capital expenditures / revenue.
D&A / revenue
7.4%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
12.6%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
14.4%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y
-128.9%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-42.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-17.3%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y
11.2%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
186.6%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.48x
Current assets / current liabilities.
Quick ratio
1.61x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.61x
(Cash + short-term investments) / current liabilities.
Free cash flow / net income, when net income is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$14.79
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$5.00
Revenue / diluted weighted shares.
FCF per share
-$2.90
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$2.80
Cash from operations / diluted weighted shares.
Book value per share
$19.91
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
0.46x
Market cap / net income. Only when net income is positive.
P/S
1.35x
Market cap / revenue.
P/B
0.30x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.30x
Market cap / tangible book value, when positive.
EV/Sales
0.58x
Enterprise value / revenue.
FCF yield
-42.8%
Free cash flow / market cap.
Earnings yield
218.4%
Net income / market cap (the inverse of P/E).
What was LanzaTech Global, Inc.'s revenue in fiscal 2025?
LanzaTech Global, Inc. reported revenue of $55.8M for fiscal 2025, 12.6% higher than the year before.
Was LanzaTech Global, Inc. profitable in fiscal 2025?
No. It reported a net loss of $49.0M.
How much free cash flow did LanzaTech Global, Inc. generate in fiscal 2025?
Cash from operations of $64.9M minus capital expenditures of $1.3M left free cash flow of -$66.1M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.